Laurent Storme
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Laurent Storme has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Pierre Lequien
Department of Neonatology, Service de Médecine Néonatale, Hôpital Jeanne de Flandre, CHRU de Lille, Lille cédex 59037, France
10 shared publications- Philippe Deruelle
Montpellier-Nîmes Faculty of Medicine, University of Montpellier, Montpellier, France
8 shared publications Yvon Riou
Department of Physiology, CHRU de Lille, Lille, France
7 shared publicationsT. Rakza
6 shared publicationsSerge Klosowski
Department of Neonatology, Hôpital Jeanne de Flandre, Centre Hospitalier Régional et Universitaire, 59037 Lille Cédex, France
5 shared publications- Thameur Rakza
Service de pédiatrie en maternité, hôpital Jeanne-de-Flandre, CHRU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France; EA 4489, faculté de médecine de Lille, 59000 Lille, France
5 shared publications
Latest Publications
- Open Access
- 18 April 2024
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 109 (6) , 586-593
Respiratory outcomes and survival after unplanned extubation in the NICU: a prospective cohort study from the SEPREVEN trial
Objective To compare reintubation rates after planned extubation and unplanned extubation (UE) in patients in neonatal intensive care units (NICUs), to analyse risk factors for reintubation after UE and to compare outcomes in patients with and without UE. Design Prospective, observational study nested in a randomised controlled trial (SEPREVEN/Study on Epidemiology and PRevention of adverse EVEnts in Neonates). Outcomes were expected to be independent of the intervention tested. Setting 12 NICUs in France with a 20-month follow-up, starting November 2015. Patients n=2280 patients with a NICU stay >2 days, postmenstrual age ≤42 weeks on admission. Interventions/exposure Characteristics of UE (context, timing, sedative administration in the preceding 6 hours, weaning from ventilation at time of UE) and patients. Main outcome measures Healthcare professional-reported UE rates, reintubation/timing after extubation, duration of mechanical ventilation, mortality and bronchopulmonary dysplasia (BPD). Results There were 162 episodes of UE (139 patients, median gestational age (IQR) 27.3 (25.6–31.7) weeks). Cumulative reintubation rates within 24 hours and 7 days of UE were, respectively, 50.0% and 57.5%, compared with 5.5% and 12.3% after a planned extubation. Independent risk factors for reintubation within 7 days included absence of weaning at the time of UE (HR, 95% CI) and sedatives in the preceding 6 hours (HR 1.93, 95% CI 1.04 to 3.60). Mortality at discharge did not differ between patients with planned extubation or UE. UE was associated with a higher risk of BPD. Conclusion In the SEPREVEN trial, reintubation followed UE in 58% of the cases, compared with 12% after planned extubation. Trial registration number NCT02598609.
- 18 April 2024
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 109 (6) , 586-593
Open AccessRespiratory outcomes and survival after unplanned extubation in the NICU: a prospective cohort study from the SEPREVEN trial
Objective To compare reintubation rates after planned extubation and unplanned extubation (UE) in patients in neonatal intensive care units (NICUs), to analyse risk factors for reintubation after UE and to compare outcomes in patients with and without UE. Design Prospective, observational study nested in a randomised controlled trial (SEPREVEN/Study on Epidemiology and PRevention of adverse EVEnts in Neonates). Outcomes were expected to be independent of the intervention tested. Setting 12 NICUs in France with a 20-month follow-up, starting November 2015. Patients n=2280 patients with a NICU stay >2 days, postmenstrual age ≤42 weeks on admission. Interventions/exposure Characteristics of UE (context, timing, sedative administration in the preceding 6 hours, weaning from ventilation at time of UE) and patients. Main outcome measures Healthcare professional-reported UE rates, reintubation/timing after extubation, duration of mechanical ventilation, mortality and bronchopulmonary dysplasia (BPD). Results There were 162 episodes of UE (139 patients, median gestational age (IQR) 27.3 (25.6–31.7) weeks). Cumulative reintubation rates within 24 hours and 7 days of UE were, respectively, 50.0% and 57.5%, compared with 5.5% and 12.3% after a planned extubation. Independent risk factors for reintubation within 7 days included absence of weaning at the time of UE (HR, 95% CI) and sedatives in the preceding 6 hours (HR 1.93, 95% CI 1.04 to 3.60). Mortality at discharge did not differ between patients with planned extubation or UE. UE was associated with a higher risk of BPD. Conclusion In the SEPREVEN trial, reintubation followed UE in 58% of the cases, compared with 12% after planned extubation. Trial registration number NCT02598609.
- 1 March 2017
- Published by Elsevier in Diabetes & Metabolism
- Vol. 43 (2) , A58-A59
Prévalence et facteurs prédictifs de l’hypoglycémie néonatale chez des enfants de mères diabétiques
- 1 March 2017
- Published by Elsevier in Diabetes & Metabolism
- Vol. 43 (2) , A58-A59
Prévalence et facteurs prédictifs de l’hypoglycémie néonatale chez des enfants de mères diabétiques
- 1 January 2015
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 7 (1) , 102
0377: Atrial septostomy in very low birth weight infants
- 1 January 2015
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 7 (1) , 102
0377: Atrial septostomy in very low birth weight infants
- 1 March 2013
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 48 (3) , 481-487
Tracheal occlusion alters pulmonary circulation in the fetal lamb with normally developing lungs
- 1 March 2013
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 48 (3) , 481-487
Tracheal occlusion alters pulmonary circulation in the fetal lamb with normally developing lungs
- 1 March 2013
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 106 (3) , 169-177
Pathophysiology of persistent pulmonary hypertension of the newborn: Impact of the perinatal environment
- 1 March 2013
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 106 (3) , 169-177
Pathophysiology of persistent pulmonary hypertension of the newborn: Impact of the perinatal environment
- 1 January 2013
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 5 (1) , 79
236: Effects and mechanisms of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation
- 1 January 2013
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 5 (1) , 79
236: Effects and mechanisms of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S106
211: Effects of Rho-kinase pathway inhibition by fasudil on growth and metabolic parameters in a rat model of intrauterine growth retardation
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S106
211: Effects of Rho-kinase pathway inhibition by fasudil on growth and metabolic parameters in a rat model of intrauterine growth retardation
- 1 June 2011
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 39 (6) , 1431-1438
Effects of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation*
Objective: Although evidence exists that n-3 polyunsaturated fatty acids may improve the outcome in patients with severe respiratory failure, little is known regarding their pulmonary circulatory effects. This question is clinically relevant in respiratory failure associated with pulmonary hypertension, in particular in newborn infants with persistent pulmonary hypertension. The objective of this study was to investigate the effects of n-3 polyunsaturated fatty acids on the fetal pulmonary circulation. Design: Randomized, placebo-controlled comparative laboratory investigation. Setting: University research facility. Subjects: Fifty-two chronically prepared lamb fetuses. Interventions: Catheters and ultrasonic flow transducer were placed through a left thoracotomy in the lamb fetus to determine aortic, pulmonary, and left atrial pressures and left pulmonary artery blood flow. Measurements and Main Results: We compared the pulmonary vascular responses to 120 mins of Omegaven (lipid emulsions enriched in n-3 polyunsaturated fatty acids) or Intralipide (lipid emulsions enriched in n-6 polyunsaturated fatty acids) infusion. Then we investigated the effects of Omegaven on the pulmonary circulation after nitric oxide synthase inhibition by l-nitro-arginine, potassium channel blockade by tetraethylammonium, and cytochrome P450 epoxygenase inhibition by (methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide. Pulmonary artery and aortic pressures as well as blood gases and plasma lactate concentrations did not change during either fat emulsion infusion. Left pulmonary blood flow increased by 30% and pulmonary vascular resistance decreased by 28% during Omegaven infusion, whereas left pulmonary blood flow and pulmonary vascular resistance did not change during Intralipide infusion. This pulmonary vascular response to Omegaven was not altered by l-nitro-arginine. At the opposite, Omegaven induced pulmonary vasodilatation was abolished by tetraethylammonium and markedly attenuated by (methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide. Conclusions: Lipid emulsion containing n-3 polyunsaturated fatty acids may induce a potent and sustained vasodilatation in the fetal lung. This pulmonary vasodilator response is mediated through production of vasoactive mediators by cytochrome P450 epoxygenase and through activation of potassium channels.
- 1 June 2011
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 39 (6) , 1431-1438
Effects of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation*
Objective: Although evidence exists that n-3 polyunsaturated fatty acids may improve the outcome in patients with severe respiratory failure, little is known regarding their pulmonary circulatory effects. This question is clinically relevant in respiratory failure associated with pulmonary hypertension, in particular in newborn infants with persistent pulmonary hypertension. The objective of this study was to investigate the effects of n-3 polyunsaturated fatty acids on the fetal pulmonary circulation. Design: Randomized, placebo-controlled comparative laboratory investigation. Setting: University research facility. Subjects: Fifty-two chronically prepared lamb fetuses. Interventions: Catheters and ultrasonic flow transducer were placed through a left thoracotomy in the lamb fetus to determine aortic, pulmonary, and left atrial pressures and left pulmonary artery blood flow. Measurements and Main Results: We compared the pulmonary vascular responses to 120 mins of Omegaven (lipid emulsions enriched in n-3 polyunsaturated fatty acids) or Intralipide (lipid emulsions enriched in n-6 polyunsaturated fatty acids) infusion. Then we investigated the effects of Omegaven on the pulmonary circulation after nitric oxide synthase inhibition by l-nitro-arginine, potassium channel blockade by tetraethylammonium, and cytochrome P450 epoxygenase inhibition by (methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide. Pulmonary artery and aortic pressures as well as blood gases and plasma lactate concentrations did not change during either fat emulsion infusion. Left pulmonary blood flow increased by 30% and pulmonary vascular resistance decreased by 28% during Omegaven infusion, whereas left pulmonary blood flow and pulmonary vascular resistance did not change during Intralipide infusion. This pulmonary vascular response to Omegaven was not altered by l-nitro-arginine. At the opposite, Omegaven induced pulmonary vasodilatation was abolished by tetraethylammonium and markedly attenuated by (methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide. Conclusions: Lipid emulsion containing n-3 polyunsaturated fatty acids may induce a potent and sustained vasodilatation in the fetal lung. This pulmonary vasodilator response is mediated through production of vasoactive mediators by cytochrome P450 epoxygenase and through activation of potassium channels.
- 31 January 2011
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 3 (1) , 100-101
304 Agenesis of the ductus arteriosus: combination with pulmonary artery hypertension
- 31 January 2011
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 3 (1) , 100-101
304 Agenesis of the ductus arteriosus: combination with pulmonary artery hypertension
- 1 September 2010
- Published by Elsevier in Archives de Pédiatrie
- Vol. 17, S85-S92
Prise en charge médicale per et post-natale de la hernie congénitale du diaphragme
- 1 September 2010
- Published by Elsevier in Archives de Pédiatrie
- Vol. 17, S85-S92
Prise en charge médicale per et post-natale de la hernie congénitale du diaphragme